Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The future of gene therapy.

Nabel GJ.

Ernst Schering Res Found Workshop. 2003;(43):1-16. Review. No abstract available.

PMID:
12894447
2.

[Strategies for gene therapy].

Kaneda Y.

Nihon Rinsho. 2005 Dec;63 Suppl 12:486-90. Review. Japanese. No abstract available.

PMID:
16416840
3.

Lentiviral vectors for gene therapy of heart disease.

Higuchi K, Medin JA.

J Cardiol. 2007 Jan;49(1):1-11. Review.

PMID:
17269208
4.

Gene therapy for cardiovascular disorders: is there a future?

Metcalfe BL, Sellers KW, Jeng MJ, Huentelman MJ, Katovich MJ, Raizada MK.

Ann N Y Acad Sci. 2001 Dec;953:31-42. Review.

PMID:
11795421
5.

Genetic therapies for cardiovascular diseases.

Melo LG, Pachori AS, Gnecchi M, Dzau VJ.

Trends Mol Med. 2005 May;11(5):240-50. Review.

PMID:
15882612
6.

Gene therapy approaches to cardiovascular disease.

Jones JM, Koch WJ.

Methods Mol Med. 2005;112:15-35. Review.

PMID:
16010008
7.

Nonviral vectors for cardiovascular gene delivery.

Wolff JA, Herweijer H.

Ernst Schering Res Found Workshop. 2003;(43):41-59. Review. No abstract available.

PMID:
12894450
8.

Gene therapy in cardiovascular disease: state of the art.

White DC, Milano CA.

Ann Surg. 2003 Dec;238(6 Suppl):S90-7; discussion S98-9. Review. No abstract available.

PMID:
14703749
9.

Gene therapy in cardiovascular disorders.

Wadhwa S.

J Assoc Physicians India. 2001 May;49:538-42. Review. No abstract available.

PMID:
11361269
10.

Does gene therapy become pharmacotherapy?

Morishita R, Aoki M, Ogihara T.

Exp Physiol. 2005 May;90(3):307-13. Review.

11.

Antioxidant gene therapy for cardiovascular disease: current status and future perspectives.

Levonen AL, Vähäkangas E, Koponen JK, Ylä-Herttuala S.

Circulation. 2008 Apr 22;117(16):2142-50. doi: 10.1161/CIRCULATIONAHA.107.718585. Review.

12.

[Current status of gene therapy in oversea countries].

Tani K.

Nihon Rinsho. 2005 Dec;63 Suppl 12:496-504. Review. Japanese. No abstract available.

PMID:
16416842
13.

Getting to the heart of things in the field of cardiovascular gene therapy.

Dickson G.

Hum Gene Ther. 2011 Aug;22(8):911-2. doi: 10.1089/hum.2011.2513. No abstract available.

PMID:
21859252
14.

Therapeutic gene regulation: targeting transcription.

Giordano FJ.

Circulation. 2007 Mar 13;115(10):1180-3. No abstract available.

15.

Development of targeted viral vectors for cardiovascular gene therapy.

Nicklin SA, Baker AH.

Genet Eng (N Y). 2003;25:15-49. Review. No abstract available.

PMID:
15260232
16.

AAV vectors and cardiovascular disease: targeting TNF receptor in the heart: clue to way forward with AAV?

Hajjar RJ, Zsebo K.

Gene Ther. 2007 Dec;14(23):1611-2. No abstract available.

PMID:
17943145
17.

Vectors for cardiovascular gene therapy.

Rosenzweig A.

J Mol Cell Cardiol. 2003 Jul;35(7):731-3. No abstract available.

PMID:
12818562
18.

Implications of human genome and modern cell biology research in management of cardiovascular diseases.

Ghosh K, Khare A, Shetty S.

Indian Heart J. 2005 May-Jun;57(3):270-3. Review. No abstract available.

PMID:
16196190
19.

Designing gene delivery vectors for cardiovascular gene therapy.

Baker AH.

Prog Biophys Mol Biol. 2004 Feb-Apr;84(2-3):279-99. Review.

PMID:
14769440
20.

Modification of cardiovascular ion channels by gene therapy.

Telemaque S, Marsh JD.

Expert Rev Cardiovasc Ther. 2009 Aug;7(8):939-53. doi: 10.1586/erc.09.76. Review.

PMID:
19673672
Items per page

Supplemental Content

Support Center